Neurology
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group.
To investigate whether antifibrinolytics in combination with treatment to prevent cerebral ischemia improve outcome in patients with subarachnoid hemorrhage (SAH) in whom occlusion of the aneurysm is delayed. ⋯ Antifibrinolytic treatment combined with treatment to prevent cerebral ischemia does not improve outcome.